354 related articles for article (PubMed ID: 18564993)
21. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
Cruzan G; Bus J; Banton M; Gingell R; Carlson G
Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
[TBL] [Abstract][Full Text] [Related]
22. Children as a sensitive subpopulation for the risk assessment process.
Preston RJ
Toxicol Appl Pharmacol; 2004 Sep; 199(2):132-41. PubMed ID: 15313585
[TBL] [Abstract][Full Text] [Related]
23. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
[TBL] [Abstract][Full Text] [Related]
24. Methods for assessing uncertainty in fundamental assumptions and associated models for cancer risk assessment.
Small MJ
Risk Anal; 2008 Oct; 28(5):1289-308. PubMed ID: 18844862
[TBL] [Abstract][Full Text] [Related]
25. A mechanism-based cancer risk assessment for 1,4-dichlorobenzene.
Butterworth BE; Aylward LL; Hays SM
Regul Toxicol Pharmacol; 2007 Nov; 49(2):138-48. PubMed ID: 17688981
[TBL] [Abstract][Full Text] [Related]
26. Evaluating genotoxicity data to identify a mode of action and its application in estimating cancer risk at low doses: A case study involving carbon tetrachloride.
Eastmond DA
Environ Mol Mutagen; 2008 Mar; 49(2):132-41. PubMed ID: 18213651
[TBL] [Abstract][Full Text] [Related]
27. Uncertainties in the CIIT model for formaldehyde-induced carcinogenicity in the rat: a limited sensitivity analysis-I.
Subramaniam RP; Crump KS; Van Landingham C; White P; Chen C; Schlosser PM
Risk Anal; 2007 Oct; 27(5):1237-54. PubMed ID: 18076493
[TBL] [Abstract][Full Text] [Related]
28. Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action.
Bogen KT; Benson JM; Yost GS; Morris JB; Dahl AR; Clewell HJ; Krishnan K; Omiecinski CJ
Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S27-36. PubMed ID: 18191315
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of alternative methods for establishing safe levels of occupational exposure to vinyl halides.
Storm JE; Rozman KK
Regul Toxicol Pharmacol; 1997 Jun; 25(3):240-55. PubMed ID: 9237327
[TBL] [Abstract][Full Text] [Related]
30. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
Sanner T; Dybing E; Willems MI; Kroese ED
Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
[TBL] [Abstract][Full Text] [Related]
31. Data considerations for regulation of water contaminants.
Schoeny R; Haber L; Dourson M
Toxicology; 2006 Apr; 221(2-3):217-24. PubMed ID: 16483704
[TBL] [Abstract][Full Text] [Related]
32. Comparison of cancer slope factors using different statistical approaches.
Subramaniam RP; White P; Cogliano VJ
Risk Anal; 2006 Jun; 26(3):825-30. PubMed ID: 16834636
[TBL] [Abstract][Full Text] [Related]
33. Critical assessment of the genetic toxicity of naphthalene.
Brusick D
Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S37-42. PubMed ID: 17980943
[TBL] [Abstract][Full Text] [Related]
34. Critical review of dose-response options for F344 rat mammary tumors for acrylamide - additional insights based on mode of action.
Maier A; Kohrman-Vincent M; Hertzberg R; Allen B; Haber LT; Dourson M
Food Chem Toxicol; 2012 May; 50(5):1763-75. PubMed ID: 22366097
[TBL] [Abstract][Full Text] [Related]
35. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
36. Unveiling variability and uncertainty for better science and decisions on cancer risks from environmental chemicals.
Bogen KT
Risk Anal; 2014 Oct; 34(10):1795-806. PubMed ID: 25407123
[TBL] [Abstract][Full Text] [Related]
37. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
[TBL] [Abstract][Full Text] [Related]
38. Is inhalation exposure to formaldehyde a biologically plausible cause of lymphohematopoietic malignancies?
Pyatt D; Natelson E; Golden R
Regul Toxicol Pharmacol; 2008 Jun; 51(1):119-33. PubMed ID: 18440686
[TBL] [Abstract][Full Text] [Related]
39. Methods for deriving pesticide aquatic life criteria.
TenBrook PL; Tjeerdema RS; Hann P; Karkoski J
Rev Environ Contam Toxicol; 2009; 199():19-109. PubMed ID: 19110939
[TBL] [Abstract][Full Text] [Related]
40. Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform.
Liao KH; Tan YM; Conolly RB; Borghoff SJ; Gargas ML; Andersen ME; Clewell HJ
Risk Anal; 2007 Dec; 27(6):1535-51. PubMed ID: 18093051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
